ArticleBritish journal of clinical pharmacology2017

Pharmacokinetics and safety of letermovir, a novel anti-human cytomegalovirus drug, in patients with renal impairment.

Dirk Kropeit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.